Teva Pharmaceutical Financials

TEVA Stock  ILA 5,214  30.00  0.57%   
We advise to exercise Teva Pharmaceutical fundamental analysis to see if markets are presently undervaluing or overvaluing the firm. In other words, this technique allows you to confirm available indicators of Teva Pharmaceutical as well as the relationship between them. We were able to interpolate thirty-six available drivers for Teva Pharmaceutical Industries, which can be compared to its competition. To ensure the equity is not overpriced, please validate all Teva Pharmaceutical financials, including its net income, cash per share, and the relationship between the ebitda and cash and equivalents . The stock experiences a moderate downward daily trend and can be a good diversifier. Check odds of Teva Pharmaceutical to be traded at 5109.72 in 90 days.
With this module, you can analyze Teva financials for your investing period. You should be able to track the changes in Teva Pharmaceutical individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
  
Understanding current and past Teva Pharmaceutical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Teva Pharmaceutical's financial statements are interrelated, with each one affecting the others. For example, an increase in Teva Pharmaceutical's assets may result in an increase in income on the income statement.
Evaluating Teva Pharmaceutical's financials involves analyzing a range of financial metrics and ratios to gain insights into the company's financial health and performance. However, considering all of Teva Pharmaceutical's profitability, liquidity ratios, and efficiency indicators at the same time could be an enormous task, and our Financial Distress score can provide you with a snapshot of the Teva Pharmaceutical's relative financial performance

Chance Of Distress

Less than 27

 
100  
 
Zero
Below Average
Teva Pharmaceutical Industries has less than 27 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Teva Pharmaceutical stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity.
Please note, Teva Pharmaceutical's odds of distress score SHOULD NOT be confused with the real chance of Teva Pharmaceutical Industries filing for bankruptcy protection for chapters 7, 11, 12, or 13. We define Financial Distress as an operational condition where an entity such as Teva is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from public financial statements and analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors considered include Teva Pharmaceutical's liquidity analysis, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
More Info
The data published in Teva Pharmaceutical's official financial statements usually reflect Teva Pharmaceutical's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Teva Pharmaceutical. For example, before you start analyzing numbers published by Teva accountants, it's critical to develop an understanding of what Teva Pharmaceutical's liquidity, profitability, and earnings quality are in the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of Teva Pharmaceutical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Teva Pharmaceutical's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Teva Pharmaceutical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Teva Pharmaceutical Industries. Please utilize our Beneish M Score to check the likelihood of Teva Pharmaceutical's management manipulating its earnings.

Teva Pharmaceutical Company Summary

Teva Pharmaceutical competes with Bank Leumi, Mizrahi Tefahot, Gazit Globe, Alony Hetz, and Delek. Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company was founded in 1901 and is based in Tel Aviv-Yafo, Israel. TEVA PHARMA is traded on Tel Aviv Stock Exchange in Israel.
Foreign Associate
  USA
InstrumentIsrael Stock View All
ExchangeTel Aviv Stock Exchange
CIK Number0000818686
ISINIL0006290147
RegionMiddle East
Business Address124 Dvora HaNevia
SectorPharmaceuticals
IndustryHealth Care
BenchmarkNYSE Composite
Websitewww.tevapharm.com
Phone(972) 3 914 8213
CurrencyILA
You should never invest in Teva Pharmaceutical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Teva Stock, because this is throwing your money away. Analyzing the key information contained in Teva Pharmaceutical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Teva Pharmaceutical Key Financial Ratios

Generally speaking, Teva Pharmaceutical's financial ratios allow both analysts and investors to convert raw data from Teva Pharmaceutical's financial statements into concise, actionable information that can be used to evaluate the performance of Teva Pharmaceutical over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Teva Pharmaceutical reports annually and quarterly.

Teva Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Teva Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Teva Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Teva Pharmaceutical competition to find correlations between indicators driving Teva Pharmaceutical's intrinsic value. More Info.
Teva Pharmaceutical Industries is currently regarded as top stock in debt to equity category among related companies. It is currently regarded as top stock in gross profit category among related companies fabricating about  3,084,033,613  of Gross Profit per Debt To Equity. . Comparative valuation analysis is a catch-all model that can be used if you cannot value Teva Pharmaceutical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Teva Pharmaceutical's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Teva Pharmaceutical's earnings, one of the primary drivers of an investment's value.

Teva Pharmaceutical Systematic Risk

Teva Pharmaceutical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Teva Pharmaceutical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Teva Pharmaceutical correlated with the market. If Beta is less than 0 Teva Pharmaceutical generally moves in the opposite direction as compared to the market. If Teva Pharmaceutical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Teva Pharmaceutical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Teva Pharmaceutical is generally in the same direction as the market. If Beta > 1 Teva Pharmaceutical moves generally in the same direction as, but more than the movement of the benchmark.

About Teva Pharmaceutical Financials

What exactly are Teva Pharmaceutical Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Teva Pharmaceutical's income statement, its balance sheet, and the statement of cash flows. Potential Teva Pharmaceutical investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Teva Pharmaceutical investors may use each financial statement separately, they are all related. The changes in Teva Pharmaceutical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Teva Pharmaceutical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.

Steps to analyze Teva Pharmaceutical Financials for Investing

There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Teva Pharmaceutical is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Teva has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.
In summary, you can determine if Teva Pharmaceutical's financials are consistent with your investment objective using the following steps:
  • Review Teva Pharmaceutical's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
  • Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
  • Study the cash flow inflows and outflows to understand Teva Pharmaceutical's liquidity and solvency.
  • Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
  • Compare Teva Pharmaceutical's financials to those of its peers to see how it stacks up and identify any potential red flags.
  • Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Teva Pharmaceutical's stock is overvalued or undervalued.
Remember, these are just guidelines and should not be the only basis for investment decisions. It is always important to analyze the leading stock market indicators., conduct additional research and seek professional advice if needed.

Teva Pharmaceutical March 29, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Teva Pharmaceutical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Teva Pharmaceutical Industries. We use our internally-developed statistical techniques to arrive at the intrinsic value of Teva Pharmaceutical Industries based on widely used predictive technical indicators. In general, we focus on analyzing Teva Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Teva Pharmaceutical's daily price indicators and compare them against related drivers.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Teva Pharmaceutical Industries. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Complementary Tools for Teva Stock analysis

When running Teva Pharmaceutical's price analysis, check to measure Teva Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharmaceutical is operating at the current time. Most of Teva Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Teva Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharmaceutical's price. Additionally, you may evaluate how the addition of Teva Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Global Correlations
Find global opportunities by holding instruments from different markets
Please note, there is a significant difference between Teva Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Teva Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Teva Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.